Compare PSMT & MMED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PSMT | MMED |
|---|---|---|
| Founded | 1994 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Department/Specialty Retail Stores | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.6B | 5.5B |
| IPO Year | 2005 | 2025 |
| Metric | PSMT | MMED |
|---|---|---|
| Price | $171.29 | $20.25 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 10 |
| Target Price | N/A | ★ $22.56 |
| AVG Volume (30 Days) | 218.5K | ★ 1.2M |
| Earning Date | 04-08-2026 | 06-03-2026 |
| Dividend Yield | ★ 0.91% | N/A |
| EPS Growth | ★ 5.47 | N/A |
| EPS | ★ 4.18 | N/A |
| Revenue | ★ $4,066,093,000.00 | $3,102,000,000.00 |
| Revenue This Year | $12.29 | $15.99 |
| Revenue Next Year | $10.70 | $10.00 |
| P/E Ratio | $42.01 | ★ N/A |
| Revenue Growth | 12.33 | ★ 14.25 |
| 52 Week Low | $105.46 | $10.65 |
| 52 Week High | $199.84 | $20.88 |
| Indicator | PSMT | MMED |
|---|---|---|
| Relative Strength Index (RSI) | 36.20 | 66.43 |
| Support Level | $165.72 | $10.68 |
| Resistance Level | $199.23 | $20.88 |
| Average True Range (ATR) | 6.18 | 0.85 |
| MACD | -1.10 | -0.04 |
| Stochastic Oscillator | 15.73 | 79.21 |
Pricesmart Inc is principally engaged in operating U.S.-style membership shopping warehouse clubs that offer consumer goods at low prices. The company is headquartered in San Diego, California, United States, and operates stores in the Caribbean, Costa Rica, Panama, and other regions. The company's revenue consists of net warehouse club sales from merchandise sales, membership income from annual membership fees, export sales, and other income. Its operations consist of four reportable segments; Central America, the Caribbean, Colombia, and the United States. A majority of the company's revenue is derived from Central America.
Minimed Group Inc is a scaled medical technology company that develops, manufactures, and markets a comprehensive suite of solutions for the management of diabetes. It serves PWD who require intensive insulin therapy, which represents all people with T1D and a subset of those with T2D. The company's platform of simple and clinically effective solutions for PWD requiring insulin therapy includes Automated Insulin Delivery (AID) Systems and Smart Multiple Daily Injection (MDI) Systems. It derives revenue from the sale of products focused on diabetes management, including insulin pumps, continuous glucose monitoring systems and sensors, and smart insulin pens. Geographically, it operates in the USA and the Rest of World, with the majority of revenue derived from the Rest of World.